Categories AlphaGraphs, Earnings, Industrials

Infographic: Highlights of Altria Group’s Q1 2022 earnings report

Tobacco company Altria Group, Inc. (NYSE: MO) has reported an increase in first-quarter profit despite a modest decrease in revenues. The company’s stock traded higher in the early hours of Friday’s session.

Altria Group Q1 2022 Earnings Infographic

First-quarter earnings, adjusted for special items, moved up to $1.12 per share from $1.07 per share in the comparable period of fiscal 2021. On an unadjusted basis, net profit increased to $1.95 billion or $1.08 per share from $1.42 billion or$0.77 per share last year.

Total revenues decreased 2% annually to $5.89 billion during the three-month period, reflecting continued weakness in the core tobacco business.


Check this space to read management/analysts’ comments on Altria’s Q1 2022 earnings


“We are off to a strong start to the year and believe our businesses are on track to deliver against their
full-year plans. Our tobacco businesses performed well in a challenging macroeconomic environment and we
continued to make progress toward our Vision to responsibly lead the transition of adult smokers to a smoke-free
future,” said Billy Gifford, chief executive officer of Altria.

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Microsoft (MSFT) reports higher revenue and profit for Q3 2024

Microsoft Corp. (NASDAQ: MSFT) on Thursday said its third-quarter 2024 earnings increased year-over-year, reflecting strong performance by the tech giant’s main operating segments. Third-quarter revenues came in at $61.86 billion,

GOOG, GOOGL Earnings: All you need to know about Alphabet’s Q1 2024 earnings results

Alphabet Inc. (NASDAQ: GOOG, GOOGL) reported its first quarter 2024 earnings results today. Revenues increased 15% year-over-year to $80.5 billion. Revenue growth was 16% in constant currency. Net income was

MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of 2024, aided by an increase in revenues. First-quarter worldwide sales

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top